Liver Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Nov 15, 2004; 10(22): 3251-3254
Published online Nov 15, 2004. doi: 10.3748/wjg.v10.i22.3251
Figure 1
Figure 1 Primary hepatic cholangiocarcinoma. Brown-yellow staining in cytoplasm of carcinoma cells for bcl-2 protein (arrowhead) Immunohistochemistry staining × 200.
Figure 2
Figure 2 Normal liver. Brown-yellow staining in cytoplasm of small bile duct epithelial cells for bcl-2 protein (arrowhead) Immunohistochemistry staining × 200.
Figure 3
Figure 3 Primary hepatic cholangiocarcinoma. Brown-yellow staining in cytoplasm of carcinoma cells for bax protein (arrowhead) Immunohistochemistry staining × 200.
Figure 4
Figure 4 Normal liver. Brown-yellow staining in cytoplasm of small bile duct epithelial cells for bax protein (arrowhead) Immunohistochemistry staining × 200.
Figure 5
Figure 5 Non-Hodgkin's lymphoma. Purple-blue deposition in nuclear of lympoma cells (positive for mbr, arrowhead). In situ PCR × 400.